IRF4 and hepatocellular carcinoma: Here, we demonstrate that IRF4 represents a novel regulator of PMN-MDSCs, but not of M-MDSCs and IRF4 expression is also negatively correlated with PMN-MDSCs levels in clinical HCC patients.